Biopharma, healthcare providers, and health insurance industry leaders discuss the issues and challenges facing the sector Tuesday, May 10 at CBIA’s Healthcare’s Future: The Post-COVID World.
The conference takes place at the Sheraton Hartford South Hotel in Rocky Hill, from 8:15-11:45 am.
Anthem Blue Cross Blue Shield of Connecticut president and CEO Lou Gianquinto and ConnectiCare president Karen Moran discuss the pandemic’s role as a catalyst for transforming the sector with Robinson+Cole's Susan Halpin.
Pfizer senior vice president Raja Mangipudy and Sema4 founder and president Eric Schadt share how the biopharma industry marshaled its R&D network and infrastructure to develop COVID treatments and vaccines, the subsequent discoveries and innovation, and the impact on future drug development.
Pullman & Comley’s Steve Cowherd moderates a conversation with Hartford HealthCare president and CEO Jeff Flaks, Connecticut Children’s Medical Center president and CEO James Shmerling, and Stamford Health president and CEO Kathleen Silard about the pandemic’s lessons and the resulting innovations and changing nature of patient care.
Teresa Bucello, Mercer partner and Connecticut health practice leader, shares insights from the employee benefits company’s extensive research, including new challenges and expectations for benefit packages while JPMorgan Chase’s Michael Manna offers a high-level view of the future of healthcare.
Media wishing to attend the event should contact CBIA’s Ali Warshavsky.
Healthcare’s Future: The Post-COVID World is made possible through the support of JPMorgan Chase Bank with additional support from Deloitte and Pullman & Comley.
CBIA is Connecticut’s largest business organization, with thousands of member companies, small and large, representing a diverse range of industries from every part of the state. For more information, please contact Ali Warshavsky (860.244.1929).